Ru.mor N_e'w*s :
Oncol *ogy M,e'd . I+n,c,. (OTC.: ONCO*) a C+ancer Treatmen t S,ol =
utions Gr-oup is s.a,i*d to h+a-v e
exp*-erienced o*v.e-r a 1000 % i_+ncrease in rev.en ues f'o_r t,h*e =
fisca+l 3'r-d quar'ter endin+g J,u.l-y-,
2+0*0+7 com-par,ed w,i,t h t.h,e pri-or y.e'a.r w hile f.iscal fo.urth =
quarte+r r.esults f'o*r 2'0*0_7 a,r.e on
trac k to exce-ed t h_i-s ye.ar=92s th_ird q*uarter results-.
O+N*C*O ad+ditional-ly p-lans to inc,r'ease servi+ce o_*fferings whi_ch =
a r.e curren__tly under+w,ay.
D,on=92t w-a*i't f_o-r t+h_e n*e,w*s to c.o m.e o,u_t a_n'd l.o,s,e =
t-h+e opp+ort*unity to g'e't in fr*ont of the
gen_eral invest ing public'. Oncolog,_y M-e*d is in a mult,ibil,lion =
dol lar i,ndus-try w-h'e,r+e
t_h_e,y a'r'e gainin.g marke.t s.hare rap idly.
C+a l l y o,u r brok,er n o+w f*o_r O_N,C,O+.
|
